Glaxo Teams Up With CRISPR Pioneers from Berkeley, UCSF: Brainstorm Health

Good afternoon, readers. It’s always fun (or at the very least interesting) when the big names align in the life sciences. To that end, British pharmaceutical giant GlaxoSmithKline is teaming up with the University of California, Berkeley and UC San Francisco on a new drug discovery project fueled by CRISPR gene-editing, the groups announced on […]

Will Functional Genomics Cure Big Pharma’s Failure Rate?

Drug discovery is a notoriously expensive and inefficient endeavor. Nine of 10 drug candidates that go through the cost-intensive, years-long clinical trial process never make it to market. That 90% failure rate–a drag on medical progress and a factor often cited by pharmaceutical companies to justify sky-high drug prices–has proven frustratingly sticky even in an […]

Data Sheet–How New Tech From A.I. to Drones is Improving Healthcare

There’s enthusiasm about the healthcare industry–I badly want to call it infectious or contagious but fear that would be in poor taste–and it is abundantly evident at Fortune‘s Brainstorm Health conference in San Diego this week. Keller Rinaudo, founder and CEO of medical-supplies-delivery-by-drones company Zipline International, wowed the audience with images of the important work […]